Skip to content

MapLight Therapeutics, Inc. MPLT Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$46.27M-8.6%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$12.12M+91.0%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$6.29M-17.4%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$9.16M+13.3%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$1.86M-13.9%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Operating income-$64.5M-174%
Net income-$60.7M-172%
EPS (diluted)-$1.34+95.4%

Balance sheet

See full
Cash & equivalents$55.7M
Total debt$5.6M
Total equity$399.8M+285%
Total assets$418.8M

Cash flow

See full
Operating cash flow-$51.2M-100%
CapEx$24.0K
Free cash flow-$51.2M

Valuation

See full
Market cap$1.39B
Enterprise value$1.34B

Returns & leverage

See full
Return on equity-216.8%
Debt / equity
Current ratio22.9×

Where this comes from

Reported directly by MapLight Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MapLight Therapeutics, Inc. 's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MapLight Therapeutics, Inc. 's operating lease ROU assets?
MapLight Therapeutics, Inc. (MPLT) reported operating lease ROU assets of $5.26M in Q1 2026.
What does operating lease ROU assets mean?
This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.